跳至主要内容
临床试验/DRKS00000232
DRKS00000232尚未招募不适用

Regulation of microRNAs in progenitor cells of patients with coronary artery disease - REMIRCAD-PC

Institute for Cardiovascular Regeneration,Centre of Molecular Medicine, Goethe-University Frankfurt0 个研究点目标入组 50 人开始时间: 2009年10月14日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Patients with documented stable coronary artery disease. Written informed consent and willigness to give a sample of 20 ml venous blood.

排除标准

  • - Active infection or fever
  • - Pregnancy or breastfeeding
  • - Chronic inflammatory disease (e.g. M. Crohn, Rheumatoid Arthritis)
  • - HIV infection or active hepatitis
  • - Neoplastic disease without documented complete remission within the past 5 years
  • - Apoplectic insult within the past 3 months
  • - Impaired renal function (creatinine >2.5 mg/dl) at the time of treatment
  • - Relevant liver disease (GOT >2 ULN, or spontaneous INR >1.5)
  • - Mental retardation
  • - Any condition that per investigator?s judgment increases the patient?s risk or excludes adequate collection of study data
  • - Participation in another clinical trial within the past 30 days

研究者

发起方
Institute for Cardiovascular Regeneration,Centre of Molecular Medicine, Goethe-University Frankfurt

相似试验